Megaloblastic anemia

Megaloblastic anemia
Other names: Megaloblastic anaemia
Peripheral blood smear showing hypersegmented neutrophils, characteristic of megaloblastic anemia.
SpecialtyHematology

Megaloblastic anemia is a type of macrocytic anemia. An anemia is a red blood cell defect that can lead to an undersupply of oxygen.[1] Megaloblastic anemia results from inhibition of DNA synthesis during red blood cell production.[2] When DNA synthesis is impaired, the cell cycle cannot progress from the G2 growth stage to the mitosis (M) stage. This leads to continuing cell growth without division, which presents as macrocytosis. Megaloblastic anemia has a rather slow onset, especially when compared to that of other anemias. The defect in red cell DNA synthesis is most often due to hypovitaminosis, specifically vitamin B12 deficiency or folate deficiency. Loss of micronutrients may also be a cause.

Megaloblastic anemia not due to hypovitaminosis may be caused by antimetabolites that poison DNA production directly, such as some chemotherapeutic or antimicrobial agents (for example azathioprine or trimethoprim).

The pathological state of megaloblastosis is characterized by many large immature and dysfunctional red blood cells (megaloblasts) in the bone marrow[3] and also by hypersegmented neutrophils (defined as the presence of neutrophils with six or more lobes or the presence of more than 3% of neutrophils with at least five lobes).[4] These hypersegmented neutrophils can be detected in the peripheral blood (using a diagnostic smear of a blood sample).

Signs and symptoms

The clinical presentation of this condition is as follows:[5]

  • Fatigue
  • Pallor
  • Lightheadedness
  • Irregular heartbeat
  • Muscle weakness

Causes

Pathophysiology

There is a defect in DNA synthesis in the rapidly dividing cells and to a lesser extent, RNA and protein synthesis are also impaired. Therefore, unbalanced cell proliferation and impaired cell division occur as a result of arrested nuclear maturation so the cells show nuclear-cytoplasmic asynchrony.

In the bone marrow, most megaloblasts are destroyed prior to entering the peripheral blood (intramedullary hemolysis) some can escape the bone marrow (macrocytes) to peripheral blood but they are destroyed by the reticulo-endothelial system (extramedullary hemolysis).

Diagnosis

a) Bone marrow aspirate b)megaloblasts with sieve-like nuclear chromatin thick arrow c)abnormal shaped stab forms thin arrow

These findings were consistent with a diagnosis of megaloblastic anemia (May Grunewald Giemsa, ×400).

The gold standard for the diagnosis of Vitamin B12 deficiency is a low blood level of Vitamin B12. A low level of blood Vitamin B12 is a finding that normally can and should be treated by injections, supplementation, or dietary or lifestyle advice, but it is not a diagnosis. Hypovitaminosis B12 can result from a number of mechanisms, including those listed above. For determination of cause, further patient history, testing, and empirical therapy may be clinically indicated.

A measurement of methylmalonic acid (methylmalonate) can provide an indirect method for partially differentiating Vitamin B12 and folate deficiencies. The level of methylmalonic acid is not elevated in folic acid deficiency. Direct measurement of blood cobalamin remains the gold standard because the test for elevated methylmalonic acid is not specific enough. Vitamin B12 is one necessary prosthetic group to the enzyme methylmalonyl-coenzyme A mutase. Vitamin B12 deficiency is but one among the conditions that can lead to dysfunction of this enzyme and a buildup of its substrate, methylmalonic acid, the elevated level of which can be detected in the urine and blood.

Due to the lack of available radioactive Vitamin B12, the Schilling test is now largely a historical artifact. The Schilling test was performed in the past to help determine the nature of the vitamin B12 deficiency. An advantage of the Schilling test was that it often included Vitamin B12 with intrinsic factor.

Blood findings

The blood film can point towards vitamin deficiency:

Blood chemistries will also show:

  • An increased lactic acid dehydrogenase (LDH) level. The isozyme is LDH-2 which is typical of the serum and hematopoietic cells.
  • Increased homocysteine and methylmalonic acid in Vitamin B12 deficiency
  • Increased homocysteine in folate deficiency

Normal levels of both methylmalonic acid and total homocysteine rule out clinically significant cobalamin deficiency with virtual certainty.[10]

Bone marrow (not normally checked in a patient suspected of megaloblastic anemia) shows megaloblastic hyperplasia.[11]

Management

Cobalamin and folate deficiency is treated via supplement administration, should the individual not be able to absorb the aforementioned vitamins administration, then permanent supplementation would be needed.In some cases the underlying cause would need to be ascertained[5]

See also

References

  1. ↑ "Anemia. Blood patient information". UK National Health Service. Retrieved 2021-05-09.{{cite web}}: CS1 maint: url-status (link)
  2. ↑ "Megaloblastic Anemia: Overview - eMedicine Hematology". Archived from the original on 2009-01-25. Retrieved 2009-02-07.
  3. ↑ "Megaloblastic (Pernicious) Anemia - Lucile Packard Children's Hospital". Archived from the original on 2008-03-23. Retrieved 2008-03-12.
  4. ↑ Bain, Barbara J.; Bates, Imelda; Laffan, Mike A. (2016-08-11). Dacie and Lewis Practical Haematology E-Book. Elsevier Health Sciences. ISBN 9780702069253. Archived from the original on 2021-04-27. Retrieved 2021-08-10.
  5. 1 2 "Anemia, Megaloblastic". NORD (National Organization for Rare Disorders). Archived from the original on 4 August 2021. Retrieved 10 November 2021.
  6. ↑ Nations, S. P.; Boyer, P. J.; Love, L. A.; Burritt, M. F.; Butz, J. A.; Wolfe, G. I.; Hynan, L. S.; Reisch, J.; Trivedi, J. R. (2008-08-26). "Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease". Neurology. 71 (9): 639–643. doi:10.1212/01.wnl.0000312375.79881.94. ISSN 1526-632X. PMID 18525032. S2CID 19614652.
  7. ↑ Spain, Rebecca I.; Leist, Thomas P.; De Sousa, Eduardo A. (February 2009). "When metals compete: a case of copper-deficiency myeloneuropathy and anemia". Nature Clinical Practice. Neurology. 5 (2): 106–111. doi:10.1038/ncpneuro1008. ISSN 1745-8358. PMID 19194390. S2CID 27892441.
  8. ↑ "Megaloblastic Anemia". MedlinePlus. 2012. Archived from the original on 30 November 2012. Retrieved 21 June 2015. Megaloblastic anemia is a blood disorder in which there is anemia with larger-than-normal red blood cells. Anemia is a condition in which the body does not have enough healthy red blood cells. Red blood cells provide oxygen to body tissues.
  9. ↑ "Megaloblastic Anemia". The Lecturio Medical Concept Library. Archived from the original on 10 August 2021. Retrieved 10 August 2021.
  10. ↑ Savage DG, Lindenbaum J, Stabler SP, Allen RH (1994). "Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies". Am. J. Med. 96 (3): 239–46. doi:10.1016/0002-9343(94)90149-X. PMID 8154512.
  11. ↑ Hoffbrand, A. Victor (2012). "Chapter 105. Megaloblastic Anemias". In Longo, D. L.; Fauci, A. S.; Kasper, D. L.; Hauser SL, S. L.; et al. (eds.). Harrison's Principles of Internal Medicine (18th ed.). New York: McGraw-Hill. Archived from the original on February 21, 2014. Retrieved October 23, 2015.
Classification
External resources
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.